Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ПОВЫШЕНИЕ УРОВНЯ В СЫВОРОТКЕ<.>)
Общее количество найденных документов : 53
Показаны документы с 1 по 20
 1-20    21-40   41-53 
1.
Anti-cytokine autoantibodies in autoimmunity: Preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis // Clin. and Exp. Immunol., 2003. Vol. 132, N 1.-С.128-136

2.
Anti-cytokine autoantibodies in autoimmunity: Preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis // Clin. and Exp. Immunol., 2003. Vol. 132, N 1.-С.128-136

3.
Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome // J. Clin. Immunol., 2005. Vol. 25, N 3.-С.189-201

4.
Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis // J. Rheumatol., 2000. Vol. 27, N 9.-С.2246-2250

5.
Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages // Ann. Rheum. Diseases, 2002. Vol. 61, N 2.-С.167-170

6.
Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events // Blood, 1998. Vol. 92, N 6.-С.2084-2092

7.
Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events // Blood, 1998. Vol. 92, N 6.-С.2084-2092

8.
Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE) // Clin. and Exp. Immunol., 1999. Vol. 116, N 3.-С.542-546

9.
Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE) // Clin. and Exp. Immunol., 1999. Vol. 116, N 3.-С.542-546

10.
High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies // Clin. and Exp. Immunol., 2003. Vol. 132, N 1.-С.158-162

11.
High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies // Clin. and Exp. Immunol., 2003. Vol. 132, N 1.-С.158-162

12.
Immunity markers in patients with Helicobacter pylori infection: Effect of eradication // Helicobacter, 2005. Vol. 10, N 5.-С.391-397

13.
Immunity markers in patients with Helicobacter pylori infection: Effect of eradication // Helicobacter, 2005. Vol. 10, N 5.-С.391-397

14.
Immunological prevention of spontaneous tumors: A new prospect? // Immunol. Lett., 2002. Vol. 80, N 2.-С.75-79

15.
Immunological prevention of spontaneous tumors: A new prospect? // Immunol. Lett., 2002. Vol. 80, N 2.-С.75-79

16.
Immunological prevention of spontaneous tumors: A new prospect? // Immunol. Lett., 2002. Vol. 80, N 2.-С.75-79

17.
Increased interleukin-10 serum levels in patients with solid tumours // Cancer Lett., 1996. Vol. 104, N 1.-С.1-5

18.
Increased serum levels of interferon-'гамма'-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis // Clin. and Exp. Immunol., 2003. Vol. 133, N 3.-С.448-453

19.
Increased serum levels of interferon-'гамма'-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis // Clin. and Exp. Immunol., 2003. Vol. 133, N 3.-С.448-453

20.
Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis- HTLV-I associated fibrosing alveolitis: Proposal of a new clinical entity // Clin. and Exp. Immunol., 2003. Vol. 133, N 3.-С.397-403

 1-20    21-40   41-53 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)